| [1] Asahara T,Murohara T,Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science, 1997,275(80):964-966.
[2] Hur J, Yoon C H, Kim H S, et al. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arteriosclerosis, Thrombosis, and Vascular Biology, 2004,24(2):288-293.
[3] Cheng C C,Chang S J,Chueh Y N, et al. Distinct angiogenesis roles and surface markers of early and late endothelial progenitor cells revealed by functional group analyses. BMC Genomics, 2013, 182(14):1-10.
[4] Sieveking D P, Buckle A, Celermajer D S,et al. Strikingly different angiogenic properties of endothelial progenitor cell subpopulations. Journal of the American College of Cardiology, 2008,51(6):660-668.
[5] Minami Y, Nakajima T, Ikutomi M,et al. Angiogenic potential of early and late outgrowth endothelial progenitor cells is dependent on the time of emergence. International Journal of Cardiology, 2015,186(2015):305-314.
[6] Peichev M, Naiyer A J, Pereira D, et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood, 2000,95(3):952-958.
[7] Case J, Mead L E, Bessler W K, et al.Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. Experimental Hematology, 2007,35(7):1109-1118.
[8] Cheng S, Chang S, Tsai T, et al. Differential expression of distinct surface markers in early endothelial progenitor cells and monocyte-derived macrophages. Gene Expression, 2013,16(1):15-24.
[9] Medina R J, O’Neill C L,Sweeney M,et al. Molecular analysis of endothelial progenitor cell (EPC) subtypes reveals two distinct cell populations with different identities. BMC Med Genomics, 2010,18(3):1-13.
[10] Sun Y, Bai W,Wang B,et al. Period 2 is essential to maintain early endothelial progenitor cell function in vitro and angiogenesis after myocardial infarction in mice. Journal of Cellular and Molecular Medicine, 2014,18(5):907-918.
[11] Colombo E, Calcaterra F,Cappelletti M,et al. Comparison of fibronectin and collagen in supporting the isolation and expansion of endothelial progenitor cells from human adult peripheral blood. Plos One, 2013,8(6):e66734.
[12] Moon S, Kim S, Park S, et al. Development of a xeno-free autologous culture system for endothelial progenitor cells derived from human umbilical cord blood. Plos One, 2013,8(9):e75224.
[13] Hager G, Holnthoner W, Wolbank S,et al. Three specific antigens to isolate endothelial progenitor cells from human liposuction material. Cytotherapy, 2013,15(11):1426-1435.
[14] Sekiguchi H, Ii M, Jujo K, et al. Improved culture-based isolation of differentiating endothelial progenitor cells from mouse bone marrow mononuclear cells. Plos One, 2011,6(12):e28639.
[15] Zhou L, Xia J, Qiu X,et al. In vitro evaluation of endothelial progenitor cells from adipose tissue as potential angiogenic cell sources for bladder angiogenesis. Plos One, 2015,10(2):e0117644.
[16] Masuda H, Iwasaki H, Kawamoto A, et al. Development of serum-free quality and quantity control culture of colony-forming endothelial progenitor cell for vasculogenesis. Stem Cells Transl Med, 2012,1:160-171.
[17] Bueno-Betí C, Novella S, Lazaro-Franco M, et al. An affordable method to obtain cultured endothelial cells from peripheral blood. Journal of Cellular and Molecular Medicine, 2013,17(11):1475-1483.
[18] D'Alessio A, Moccia F, Li J,et al, Angiogenesis and vasculogenesis in health and disease. BioMed Research International, 2015,2015:1-2.
[19] Hecht N, Schneider U C, Czabanka M,et al, Endothelial progenitor cells augment collateralization and hemodynamic rescue in a model of chronic cerebral ischemia. J Cereb Blood Flow Metab, 2014,34(8):1297-1305.
[20] Iskander A,Knight R A,Zhang Z G, et al. Intravenous administration of human umbilical cord blood-derived AC133 γ endothelial progenitor cells in rat stroke model reduces infarct volume: magnetic resonance imaging and histological findings. Stem Cells Translational Medicine, 2013,2(2013):703-714.
[21] Bai Y Y, Peng X G, Wang L S, et al. Bone marrow endothelial progenitor cell transplantation after ischemic stroke: an investigation into its possible mechanism. CNS Neurosci Ther, 2015,21(11):877-886.
[22] Safar M M, Arab H H, Rizk S M, et al. Bone marrow-derived endothelial progenitor cells protect against scopolamine-induced alzheimer-like pathological aberrations. Molecular Neurobiology, 2016,53(3):1403-1418.
[23] Cao G, Liu C, Wan Z, et al.Combined hypoxia inducible factor-1α and homogeneous endothelial progenitor cell therapy attenuates shunt flow-induced pulmonary arterial hypertension in rabbits. The Journal of Thoracic and Cardiovascular Surgery, 2015,150(3):621-632.
[24] Kawamoto A, Katayama M, Handa N, et al. Intramuscular transplantation of G-CSF-mobilized CD34+ cells in patients with critical limb ischemia: A phase I/IIa, multicenter, single-blinded, dose-escalation clinical trial. Stem Cells, 2009,27(2009):2857-2864.
[25] Murphy M P, Lawson J H, Rapp B M, et al.Autologous bone marrow mononuclear cell therapy is safe and promotes amputation-free survival in patients with critical limb ischemia. Journal of Vascular Surgery, 2011,53(6):1565-1574.
[26] Teraa M, Sprengers R W, Schutgens R E,et al.Effect of repetitive intra-arterial infusion of bone marrow mononuclear cells in patients with no-option limb ischemia: The randomized, double-blind, placebo-controlled rejuvenating endothelial progenitor cells via transcutaneous intra-arterial supplementation (JUVENTAS) trial. Circulation, 2015,131(10):851-860.
[27] Tanaka R, Masuda H, Kato S,et al.Autologous G-CSF-mobilized peripheral blood CD34+ cell therapy for diabetic patients with chronic nonhealing ulcer. Cell Transplantation, 2014,23(2):167-179.
[28] Jimenez-Quevedo P,Gonzalez-Ferrer J J,Sabate M,et al.Selected CD133+ progenitor cells to promote angiogenesis in patients with refractory angina: Final results of the progenitor randomized trial. Circulation Research, 2014,115(11):950-960.
[29] Lee F, Chen Y, Sung P, et al. Intracoronary transfusion of circulation-derived CD34+ cells improves left ventricular function in patients with end-stage diffuse coronary artery disease unsuitable for coronary intervention. Critical Care Medicine, 2015,43(10):2117-2132.
[30] Lee J S, Hong J M, Moon G J, et al.A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke. Stem Cells, 2010,28(6):1099-1106.
[31] Wang X X, Zhang F R, Shang Y P, et al.Transplantation of autologous endothelial progenitor cells may be beneficial in patients with idiopathic pulmonary arterial hypertension: a pilot randomized controlled trial. J Am Coll Cardiol, 2007,49(14):1566-1571.
[32] Takahashi M, Nakamura T, Toba T, et al. Transplantation of endothelial progenitor cells into the lung to alleviate pulmonary hypertension in dogs. Tissue Eng, 2004,10(5-6):771-779.
[33] Maldonado G E, Pérez C A, Covarrubias E E, et al.Autologous stem cells for the treatment of post-mastectomy lymphedema: a pilot study. Cytotherapy, 2011,13(10):1249-1255.
[34] Nash R A, McSweeney P A, Crofford L J, et al. High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study. Blood. 2007,110(4):1388-1396.
[35] Arici V, Bozzani A, Ragni F, et al.Autologous endothelial progenitor cells derived from peripheral blood for the treatment of critical limb ischemia in no-option patients: pilot study, Ital J Vas Endovasc Surg,2010,17(3):11-14.
[36] Kinoshita M, Fujita Y, Katayama M, et al.Long-term clinical outcome after intramuscular transplantation of granulocyte colony stimulating factor-mobilized CD34 positive cells in patients with critical limb ischemia. Atherosclerosis, 2012,224(2):440-445.
[37] Invernici G, Emanueli C, Madeddu P, et al. Human fetal aorta contains vascular progenitor cells capable of inducing vasculogenesis, angiogenesis, and myogenesis in vitro and in a murine model of peripheral ischemia. Am J Pathol, 2007,170(6): 1879-1892.
[38] Khera M, Albersen M, Mulhall J P, et al. Mesenchymal stem cell therapy for the treatment of erectile dysfunction. J Sex Med, 2015,12(5):1105-1106.
[39] Maione C, Botti C, Coppola C A, et al.Effect of autologous transplantation of bone marrow cells concentrated with the MarrowXpress system in patients with critical limb ischemia. Transplant Proc, 2013,45(1):402-406. |
